(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest
Portfolio Pulse from Benzinga Insights
Iovance Biotherapeutics (NYSE:IOVA) has seen a decrease in short interest, now at 16.64% of float, down 6.67% from the last report. With 42.98 million shares sold short, it would take about 7.73 days to cover all short positions. This change in short interest could indicate a shift in market sentiment towards IOVA, potentially signaling a more bullish outlook compared to its peers, which have an average short interest of 10.54%.
March 01, 2024 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Iovance Biotherapeutics's short interest has decreased, indicating a potential shift towards a more bullish market sentiment.
A decrease in short interest typically suggests that investors are becoming more optimistic about a stock's future performance. For IOVA, this reduction in short interest could reduce selling pressure and potentially lead to a price increase in the short term, especially considering it's higher than its peer group average.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100